TP53 and urinary bladder cancer: In addition to the sample set used in the previous study (4), a new set of sample was recruited, and the results partially replicated our previous findings of genotype Pro/Pro of p53 codon 72 polymorphism associated with bladder cancer staging (4), but with age and gender controlled, the results did not support its role in risk modulation of bladder cancer incidence.